BeStock  
Stocks › Biotechnology › SGP

SpyGlass Pharma SGP

US equityMarket cap rank #3409Biotechnology
$23.90 −$0.88 (-3.55%)
Market closed · Oct 8, 4:10 am ET · Last extended-hours $23.90 0.00%
Open$24.46
Prev close$24.78
Day range$23.62 – $24.76
Volume69.5K
Market cap$799.41M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$21.97M-136.3% YoY
Net profit-$19.86M-129.0% YoY
Diluted EPS-$0.59-117.0% YoY
Free cash flow-$16.77M-163.0% YoY
Operating cash flow-$14.84M

Revenue, last 7 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 7 quarters

$-8.4MDec '24$-8.8MMar '25$-8.7MJun '25$-9.8MSep '25$-12.6MDec '25$-13.8MMar '26$-19.9MJun '26

Diluted EPS by quarter

-0.47Dec '24-0.49Mar '25-0.27Jun '25-0.31Sep '25-0.39Dec '25-0.69Mar '26-0.59Jun '26

Free cash flow by quarter

$-6.7MDec '24$-8.4MMar '25$-6.4MJun '25$-9.0MSep '25$-9.8MDec '25$-14.2MMar '26$-16.8MJun '26

Annual revenue

$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-24.1%
Return on assets-23.0%
Return on invested capital-26.5%
Current ratio25.06
Liabilities / assets4.5%
Cash & investments$234.19M
Total debt$1.63M
Net cash (debt)$232.55M

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
-Long Term Capital Lease Obligation $1.63M $1.61M $1.58M $1.58M $3.09M
-Accumulated Depreciation -$1.77M -$1.43M -$1.11M -$1.11M -$933,747.00
-Gross PPE $7.99M $5.67M $5.01M $5.01M $6.06M
Net PPE $6.21M $4.24M $3.89M $3.89M $5.13M
Total Non-Current Assets $6.97M $5.02M $7.10M $7.10M $7.32M
Other Current Assets $1.60M – – – $10,422.00
-Other Receivables $678,000.00 $653,000.00 $431,000.00 $431,000.00 $418,007.00
Receivables $678,000.00 $653,000.00 $431,000.00 $431,000.00 $418,007.00
-Short Term Investments $11.04M $12.10M $11.08M $11.08M $12.03M
Long Term Debt and Capital Lease Obligation $1.63M $1.61M $1.58M $1.58M $3.09M
Total Non-Current Liabilities $1.63M $1.61M $206.12M $206.12M $207.63M
Other Current Liabilities $3.56M $2.27M $3.71M $3.71M $3.16M
-Accounts Payable $4.16M $3.51M $2.70M $2.70M $1.68M
Payables $4.16M $3.51M $2.70M $2.70M $1.68M
Total Current Liabilities $9.44M $6.67M $8.58M $8.58M $6.61M
Other Non-Current Assets $759,000.00 $789,000.00 $492,000.00 $492,000.00 $477,033.00
Non-Current Deferred Assets $0.00 $0.00 $2.72M $2.72M $1.71M
-Cash and Cash Equivalents $223.14M $238.90M $96.36M $96.36M $106.01M
Cash and Cash Equivalents & Short-Term Investments $234.19M $251.00M $107.44M $107.44M $118.04M
Total Current Assets $236.46M $253.36M $108.77M $108.77M $119.70M
Total Assets $243.43M $258.39M $115.87M $115.87M $127.01M
Convertible preferred securities $0.00 $0.00 $204.54M $204.54M $204.54M
Total Liabilities $11.07M $8.27M $214.70M $214.70M $214.24M
Retained Earnings -$138.41M -$118.55M -$104.73M -$104.73M -$92.18M
Additional Paid-In Capital $370.78M $368.66M $5.89M $5.89M $4.95M
-Preferred Stock $0.00 $0.00 – – –
Total Equity $232.36M $250.11M -$98.84M -$98.84M -$87.22M
-Common Stock $0.00 $0.00 $0.00 $0.00 $41.00
Capital Stock $0.00 $0.00 $0.00 $0.00 $41.00
Stockholders' Equity $232.36M $250.11M -$98.84M -$98.84M -$87.22M
Prepaid Assets – $1.71M $901,000.00 $901,000.00 $1.23M
-Current Capital Lease Obligation – – $0.00 $0.00 $479,438.00
Short-Term Debt and Capital Lease Obligation – – – – $479,438.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Proceeds from Stock Option Exercised $31,000.00 $55,000.00 $170,000.00 $19,846.00 $39,154.00
Net Preferred Stock Issuance $0.00 $0.00 $127.34M $279.00 -$279.00
Net Common Stock Issuance $0.00 $160.43M -$1.45M $0.00 $0.00
Net Other Financing Charges -$18,000.00 -$2.73M -$1.47M -$909,768.00 -$273,232.00
Ending Cash Balance $223.14M $238.90M $96.36M $96.36M $106.01M
-Change in Other Current Assets $30,000.00 -$298,000.00 -$38,000.00 -$232,974.00 $158,974.00
Beginning Cash Balance $238.90M $96.36M $16.27M $106.01M $127.24M
Net Change in Cash -$15.76M $142.54M $80.09M -$9.65M -$21.23M
-Change in Other Current Liabilities $759,000.00 -$79,000.00 -$441,000.00 -$112,458.00 -$37,542.00
Net cash flow from investing -$933,000.00 -$1.67M -$11.79M $574,698.00 -$12.15M
Net Cash Flow from Continuing Investing Activities -$933,000.00 -$1.67M -$11.79M $574,698.00 -$12.15M
Net PPE Purchase and Sale -$1.93M -$676,000.00 -$789,000.00 -$420,492.00 -$152,508.00
Net Investment Purchase and Sale $999,000.00 -$991,000.00 -$11.01M $995,190.00 -$12.00M
Financing Cash Flow $13,000.00 $157.76M $124.59M -$889,643.00 -$234,357.00
Net Cash Flow from Continuing Financing Activities $13,000.00 $157.76M $124.59M -$889,643.00 -$234,357.00
Net cash flow from continuing operations -$14.84M -$13.54M -$32.70M -$9.33M -$8.84M
Operating Cash Flow -$14.84M -$13.54M -$32.70M -$9.33M -$8.84M
Free Cash Flow -$16.77M -$14.22M -$33.49M -$9.75M -$8.99M
Net Income from Continuing Operations -$19.86M -$13.82M -$39.87M -$12.56M -$9.82M
Depreciation & Depletion & Amortization $342,000.00 $318,000.00 $612,000.00 $216,726.00 $137,274.00
Other Non-Cash Items $120,000.00 $32,000.00 -$209,000.00 -$479,952.00 $70,952.00
-Change in Payables and Accrued Expense $1.61M -$347,000.00 $3.12M $2.36M $441,831.00
-Change in Prepaid Assets $109,000.00 -$805,000.00 -$186,000.00 $556,897.00 -$855,897.00
Change in Working Capital $2.48M -$1.75M $2.45M $2.56M -$164,948.00
-Change in Receivables -$25,000.00 -$222,000.00 -$8,000.00 -$12,686.00 $127,686.00
Gain/Loss from Continuing Operations – – $5,000.00 $1,095.00 -$95.00

Income statement

Line item 2026 Q2 2026 Q1 2025 Q4 2025 ANNUAL 2025 Q3
Profit from Continuing Operations -$19.86M -$13.82M -$12.56M -$39.87M -$9.82M
Net Profit -$19.86M -$13.82M -$12.56M -$39.87M -$9.82M
Tax $0.00 $0.00 $0.00 $0.00 $0.00
Pretax Profit -$19.86M -$13.82M -$12.56M -$39.87M -$9.82M
Non-Operating Interest Income $2.10M $1.59M $1.07M $3.11M $1.29M
Net Non-Operating Interest Income (Expense) $2.10M $1.59M $1.07M $3.11M $1.29M
Operating Profit -$21.97M -$15.41M -$13.63M -$41.45M -$11.10M
Research & Development $10.94M $8.54M $7.71M $29.18M $8.09M
-General & Admin Expense $11.03M $6.87M $5.92M $12.27M $3.01M
Selling and Admin Expenses $11.03M $6.87M $5.92M $12.27M $3.01M
Operating Expense $21.97M $15.41M $13.63M $41.45M $11.10M
Net Income to Parent Company -$19.86M -$13.82M -$12.56M -$39.87M -$9.82M
Net Income to Common Stockholders -$19.86M -$13.82M -$12.56M -$39.87M -$9.82M
Diluted EPS -$0.59 -$0.69 -$0.39 -$1.25 -$0.31
Basic EPS -$0.59 -$0.69 -$0.39 -$1.25 -$0.31
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Other Non-Operating Income (Expenses) – – $11.00 -$1.53M -$11.00
Other Income (Expense) – – $11.00 -$1.53M -$11.00

Discussion

No comments yet — be the first to weigh in on SGP.

Leave a comment

Scroll to Top